Addition of an alternate supplier for human placental (hp) dna which is a component of the pathvysion her-2 dna probe kit and the urovysion bladder cancer kit.
Device | UROVYSION BLADDER CANCER KIT |
Classification Name | Test, Fluorescence In Situ Hybridization (fish), For Bladder Cancer Detection And Monitoring For Recurrence |
Generic Name | Test, Fluorescence In Situ Hybridization (fish), For Bladder Cancer Detection And Monitoring For Recurrence |
Applicant | ABBOTT MOLECULAR |
Date Received | 2013-01-16 |
Decision Date | 2013-02-10 |
PMA | P030052 |
Supplement | S011 |
Product Code | NSD |
Advisory Committee | Pathology |
Supplement Type | 30-day Notice |
Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier |
Expedited Review | No |
Combination Product | No |
Applicant Address | ABBOTT MOLECULAR 1300 E. Touhy Avenue des Plaines, IL 60018 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P030052 | | Original Filing |
S028 |
2022-02-18 |
30-day Notice |
S027 |
2020-11-16 |
30-day Notice |
S026 |
2019-07-31 |
30-day Notice |
S025 |
2019-04-10 |
30-day Notice |
S024 |
2018-08-10 |
30-day Notice |
S023 |
2018-06-15 |
30-day Notice |
S022 |
2018-02-16 |
30-day Notice |
S021 |
2017-11-08 |
30-day Notice |
S020 |
2016-11-22 |
Real-time Process |
S019 |
2016-09-12 |
30-day Notice |
S018 |
2016-09-02 |
30-day Notice |
S017 |
2015-11-12 |
135 Review Track For 30-day Notice |
S016 |
2014-07-24 |
30-day Notice |
S015 |
2014-06-16 |
30-day Notice |
S014 |
2013-11-25 |
30-day Notice |
S013 |
2013-11-05 |
30-day Notice |
S012 |
2013-08-29 |
Normal 180 Day Track No User Fee |
S011 |
2013-01-16 |
30-day Notice |
S010 |
2012-10-25 |
Special (immediate Track) |
S009 |
2012-07-13 |
30-day Notice |
S008 |
2011-06-23 |
30-day Notice |
S007 |
2011-05-06 |
30-day Notice |
S006 |
2011-04-28 |
Special (immediate Track) |
S005 |
2011-03-18 |
30-day Notice |
S004 |
2011-02-25 |
Special (immediate Track) |
S003 |
2009-01-26 |
30-day Notice |
S002 |
2007-01-08 |
Real-time Process |
S001 |
2005-06-20 |
Normal 180 Day Track No User Fee |
NIH GUDID Devices